The at-home treatment could assist people who are unable to travel to immunization appointments. | Photo by Jeff Gritchen/Digital First Media/Orange County Register via Getty Images
The Food and Drug Administration has approved a nasally-administered influenza immunization treatment that can be taken at home. FluMist — a nasal spray vaccine that AstraZeneca initially developed as an in-office treatment two decades ago — will still require a prescription to obtain and is expected to be made available via a new online pharmacy next year, Read Entire Article
